Inventor · disambiguated record
Daniel A. Lawrence
Also filed as: LAWRENCE DANIEL · LAWRENCE DANIEL A
26 granted patents·9 pending applications·139 citations·filing 1994–2025
95Inventor score
Files withUNIV MICHIGAN REGENTS7UNIV MICHIGAN6AMERICAN NAT RED CROSS4HUMAN GENOME SCIENCES INC3CSL LTD2
Top patents by PatentIndex Score
35 records- 0185US10961304B2Method of reducing the effect of a stroke comprising administering an inhibitor of vascular endothelial growth factor B (VEGF-B)CSL LTD·Filed 2019·Granted Mar 30, 2021·2 cites·20 claims
- 0283US11426368B2Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of useUNIV MICHIGAN REGENTS·Filed 2018·Granted Aug 30, 2022·1 cites·1 claims
- 0380US9487579B2Methods and compositions for modulation of blood-neural barrierLUDWIG INST CANCER RES·Filed 2014·Granted Nov 8, 2016·3 cites·21 claims
- 0480US6541452B1Brain-associated inhibitor of tissue-type plasminogen activatorHUMAN GENOME SCIENCES INC·Filed 2000·Granted Apr 1, 2003·7 cites·9 claims
- 0579US8147828B2Methods and compositions for modulation of blood-neural barrierERIKSSON ULF·Filed 2007·Granted Apr 3, 2012·3 cites·5 claims
- 0678US8765671B2Methods and compositions for modulation of blood-neural barrierERIKSSON ULF·Filed 2012·Granted Jul 1, 2014·3 cites·10 claims
- 0778US8759327B2Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolismLAWRENCE DANIEL A·Filed 2008·Granted Jun 24, 2014·4 cites·11 claims
- 0876US12390427B2Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of useUNIV MICHIGAN·Filed 2022·Granted Aug 19, 2025·0 cites·4 claims
- 0975US9718760B2Plasminogen activator inhibitor-1 inhibitors and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2013·Granted Aug 1, 2017·2 cites·12 claims
- 1075US9120744B2Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolismLAWRENCE DANIEL A·Filed 2009·Granted Sep 1, 2015·4 cites·22 claims
- 1175US2025345293A1Plasminogen Activator Inhibitor-1 (PAI-1) Inhibitor and Method of UseUNIV MICHIGAN REGENTS·Filed 2025·Application pending·0 cites
- 1274US5639726APeptide mediated enhancement of thrombolysis methods and compositionsUNIV MICHIGAN·Filed 1994·Granted Jun 17, 1997·46 cites·59 claims
- 1373US10336821B2Method of treating stroke by administering a compound that inhibits VEGF-B signaling in combination with a thrombolytic agentCSL LTD·Filed 2015·Granted Jul 2, 2019·1 cites·16 claims
- 1473US7713924B2Methods for treating conditions associated with the accumulation of excess extracellular matrixUNIV UTAH RES FOUND·Filed 2004·Granted May 11, 2010·4 cites·22 claims
- 1571US6103498AMutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereofAMERICAN NAT RED CROSS·Filed 1997·Granted Aug 15, 2000·22 cites·14 claims
- 1670US7235529B2Brain-associated inhibitor of tissue-type plasminogen activatorUNIV MICHIGAN·Filed 2004·Granted Jun 26, 2007·1 cites·2 claims
- 1770US7087574B2Brain associated inhibitor of tissue-type plasminogen activatorAMERICAN NAT RED CROSS·Filed 2003·Granted Aug 8, 2006·3 cites·9 claims
- 1867US6008020ABrain-associated inhibitor of tissue-type plasminogen activatorHUMAN GENOME SCIENCES·Filed 1997·Granted Dec 28, 1999·13 cites·43 claims
- 1966US10676527B2Methods and compositions for modulation of blood-neural barrierLUDWIG INST FOR CANCER RES LTD·Filed 2018·Granted Jun 9, 2020·0 cites·5 claims
- 2063US7388074B2Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereofUNIV MICHIGAN·Filed 2002·Granted Jun 17, 2008·1 cites·13 claims
- 2161US9926372B2Methods and compositions for modulation of blood-neural barrierLUDWIG INST FOR CANCER RES LTD·Filed 2016·Granted Mar 27, 2018·0 cites·22 claims
- 2260US9096501B2Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolismUNIV MICHIGAN·Filed 2014·Granted Aug 4, 2015·0 cites·6 claims
- 2360US7375076B2Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful thereinUNIV MICHIGAN·Filed 2004·Granted May 20, 2008·3 cites·18 claims
- 2454US6489143B1Mutant plasminogen activator-inhibitor type 1 (PAI-1) proteinsAMERICAN NAT RED CROSS·Filed 1999·Granted Dec 3, 2002·7 cites·15 claims
- 2553US2022372111A1Polypeptide inhibitors of neutrophil elastase activity and uses thereofUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 2651US6191260B1Brain-associated inhibitor of tissue-type plasminogen activatorAMERICAN NAT RED CROSS·Filed 1999·Granted Feb 20, 2001·9 cites·49 claims
- 2750US2002143165A1Brain-associated inhibitor of tissue-type plasminogen activatorHUMAN GENOME SCIENCES INC·Filed 2001·Application pending·0 cites
- 2848US2017291893A1Plasminogen activator inhibitor-1 inhibitors and methods of use thereofUNIV MICHIGAN REGENTS·Filed 2017·Application pending·0 cites
- 2947US2002165147A1Brain-associated inhibitor of tissue-type plasminogen activatorFiled 2001·Application pending·0 cites
- 3046US9527878B2Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolismUNIV MICHIGAN REGENTS·Filed 2015·Granted Dec 27, 2016·0 cites·20 claims
- 3146US2019076510A1Protein kinase c inhibition to extend tissue plasminogen activator treatment for ischemic diseaseUNIV MICHIGAN REGENTS·Filed 2018·Application pending·0 cites
- 3245US2007259806A1Brain-Associated Inhibitor of Tissue-Type Plasminogen ActivatorHUMAN GENOME SCIENCES INC·Filed 2007·Application pending·0 cites
- 3337US7264953B2Mutant proteinase-inhibitors and uses thereofWYETH CORP·Filed 2002·Granted Sep 4, 2007·0 cites·4 claims
- 3437US2006121591A1Mutant proteinase-inhibitors and uses thereofWYETH CORP·Filed 2006·Application pending·0 cites
- 3534US2010286053A1Plasminogen activator inhibitor amelioration of newborn hypoxic ischemic brain injuryCHILDRENS HOSP MEDICAL CENTER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel A. Lawrence files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →